The Readout
Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Here’s our web archive of the free email newsletter delivered daily, Monday through Friday.
Latest
BioNTech is having its Pfizer moment
Novo is building a really big computer
STAT Plus: Contineum Therapeutics files for IPO
STAT Plus: What happens when an approved drug doesn’t work?
STAT Plus: Is CAR-T safe for early-stage patients?
STAT Plus: Geron’s resurgence might have been short-lived
STAT Plus: When did Wall Street sour on Lilly’s Alzheimer’s drug?
All Coverage
